Latest Partners Real Estate (PTSRF) Headlines
Post# of 4
Posted On: 03/11/2014 2:51:44 AM
Latest Partners Real Estate (PTSRF) Headlines
Partners Real Estate Investment Trust Announces Amendments to Unitholder Rights Plan
Marketwire - Tue Feb 25, 3:45PM CST
Partners Real Estate Investment Trust (TSX: PAR.UN) (the "REIT") announces that it has amended the terms of the REIT's existing unitholder rights plan (the "Rights Plan") to increase the triggering threshold from 15% to 20%. In connection with its recent review of governance matters, the REIT's Board of Trustees has carefully reviewed the Rights Plan, giving particular consideration to:
Research and Markets Adds Report: Refrigerated Display Cases Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 - 2019
Close-Up Media - Thu Feb 20, 11:32PM CST
Research and Markets has announced the addition of the "Refrigerated Display Cases Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 - 2019" report to its offerings.
Partners Real Estate Investment Trust (TSX: PAR.UN) Announces Distribution of $0.04167 Per Unit
Marketwire - Fri Feb 14, 7:22PM CST
Partners Real Estate Investment Trust ("Partners REIT") (TSX: PAR.UN) is pleased to announce a $0.04167 per unit distribution for February 2014. The distribution will be paid on March 17, 2014 to unitholders of record on February 28, 2014.
Partners Real Estate Investment Trust Completes Management Internalization
Marketwire - Fri Feb 14, 3:06PM CST
Partners Real Estate Investment Trust (TSX: PAR.UN) (the "REIT") is pleased to announce that it has terminated its management agreement with McCowan & Associates Ltd. ("McCowan") and completed the internalization of its management, effective February 15, 2014.
Partners Real Estate Investment Trust Announces Senior Management Changes and Update on Ontario Property Acquisition
Marketwire - Tue Feb 11, 1:17PM CST
Partners Real Estate Investment Trust (TSX: PAR.UN) (the "REIT") is pleased to announce the appointments of Ron McCowan as interim-Chief Executive Officer and President and Derrick W. West as Chief Financial Officer effective immediately. Both appointments have been made pursuant to the REIT's management agreement which will be terminated on February 15, 2014 in connection with the previously announced proposed internalization of the REIT's management. Mr. McCowan and Mr. West will continue in these capacities on completion of the internalization process and more details regarding the REIT's internalization are expected to be announced on or about February 14, 2014.
Global Heart Valves and Transcatheter Valves Market Forecast & Opportunities, 2016
M2 - Fri Jan 17, 9:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/s5lnth/global_heart) has announced the addition of the "Global Heart Valves and Transcatheter Valves Market Forecast & Opportunities, 2016" report to their offering. According to the report,it is estimated that by 2020, 15-25 percent of the population in developed countries would be > 65 year. Heart valve diseases are more common in the elderly especially in the ages > 60-65. A greater number of elderly populations are expected to adopt heart valve repair or replacement therapies owing to access to a healthcare infrastructure. Further, developing countries are also revamping their healthcare infrastructures and enabling accessibility. This in turn is expected to boost market growth in developing countries. Partnerships such as collaboration toward development of new products or manufacturing medical devices are growing among vendors. For example, Boston Scientific partnered with Sorin Group in July 2013 for manufacturing of its product Lotus Transcatheter heart valve system. Through this partnership, Boston Scientific is expected to compete with the top vendors such as Edward Lifesciences and Medtronic in the Transcatheter Heart Valve market in Europe. Further, the report states that the high cost associated with open heart surgeries and minimally non-invasive methods of valve replacement methods like TAVR are likely to restrict the market to affluent patients. The scenario is likely to impact during most of the forecast period. However, by 2020, the market is expected to witness an increase in availability of THV equipment and competition among vendors could decrease the cost of these devices and improve the adoption rate in the future. The key vendors dominating this market space are: - Edward Life Science Corp. - Medtronic Inc. - Sorin Group - St Jude Medical Inc Key Topics Covered: 01. Executive Summary 02. Scope of the Report 03. Market Research Methodology 04. List of Abbreviations 05. Introduction 06. Market Landscape 07. Market Segmentation by Category 08. Global Heart Valve Market 09. Market Segmentation of Heart Valve Market 10. Global Transcatheter Heart Valve Market 11. Geographical Segmentation 12. Key Leading Countries 13. Buying Criteria 14. Market Growth Drivers 15. Drivers and their Impact 16. Market Challenges 17. Impact of Drivers and Challenges 18. Market Trends 19. Trends and their Impact 20. Vendor Landscape 21. Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/s5...obal_heart
Chinese Varicella Vaccine Market Report 2013
M2 - Fri Jan 17, 9:31AM CST
Research and Markets (http://www.researchandmarkets.com/research/3bc6nc/2013_deep) has announced the addition of the "Chinese Varicella Vaccine Market Report 2013" report to their offering. "Chinese Varicella Vaccine Market Report 2013", is a concise and in-depth research report on the Chinese Varicella Vaccine industry. The report begins by giving a definition of varicella vaccine including information on classification, industry chain and other related information. The data analyses manufacturing technology and product specifications and gives summary statistics on major manufacturers including details on capacity, production, supply, demand, shortage, selling price, cost, gross margin, production value and Chinese market share. The report also discusses the 4 Million Bottles/year Varicella Vaccine project feasibility analysis and investment return analysis, and gives related research conclusions and a development trend analysis of the industry. Key Topics Covered: 1 Varicella Vaccine Industry Overview 2 Varicella Vaccine Industry Chain Analysis 3 Varicella Vaccine Production Supply Sales Demand Market Status and Forecast 4 Varicella Vaccine Key Manufacturers Research 5 Varicella Vaccine New Project Investment Feasibility Analysis 6 Varicella Vaccine Industry Research Conclusions Companies Mentioned - Changchun BCHT Biotechnology - Changchun Changsheng Life Sciences Ltd - Changchun Keygen Biological Products Co.,Ltd - GlaxoSmithKline - Shanghai Institute of Biological Products Co.,Ltd For more information visit http://www.researchandmarkets.com/research/3bc6nc/2013_deep About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Partners Real Estate Investment Trust Announces Closing of Assignment of Management Agreement
Marketwire - Sun Dec 29, 7:01PM CST
Partners REIT (TSX: PAR.UN) (the "REIT" or "Partners REIT") is pleased to announce the closing of the proposed acquisition by McCowan and Associates Ltd. ("McCowan") of the rights and duties of League Asset Corp. and certain related entities ("League") under the REIT's existing management agreement (the "Transaction"). The Transaction was previously announced on December 15, 2013.
Partners Real Estate Investment Trust to Acquire Four New Ontario Properties
Marketwire - Wed Dec 18, 9:01PM CST
Partners Real Estate Investment Trust (TSX: PAR.UN) (the "REIT" or "Partners REIT") announced today that it has entered into an purchase and sale agreement (the "Agreement") to acquire four retail centers in Ontario (collectively, the "Properties"). The Properties are located in Hamilton, London, Kemptville and North Bay and total approximately 695,500 square feet of gross leasable area. The tenant roster of the Properties includes Shoppers Drug Mart, Winners, Giant Tiger and Dollar Tree. The Properties are estimated to generate annualized Net Operating Income in the aggregate of approximately $7,250,000.
Partners Real Estate Investment Trust Announces Proposal to Stabilize the REIT's Management and to Accelerate Internalization Plans
Marketwire - Sun Dec 15, 7:01PM CST
Partners REIT (TSX: PAR.UN) (the "REIT" or "Partners REIT") announced today that the Board of Trustees has entered into an arrangement intended to accelerate the REIT's internalization to no later than February 15, 2014.
Partners Real Estate Investment Trust Announces Amendments to Unitholder Rights Plan
Marketwire - Tue Feb 25, 3:45PM CST
Partners Real Estate Investment Trust (TSX: PAR.UN) (the "REIT") announces that it has amended the terms of the REIT's existing unitholder rights plan (the "Rights Plan") to increase the triggering threshold from 15% to 20%. In connection with its recent review of governance matters, the REIT's Board of Trustees has carefully reviewed the Rights Plan, giving particular consideration to:
Research and Markets Adds Report: Refrigerated Display Cases Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 - 2019
Close-Up Media - Thu Feb 20, 11:32PM CST
Research and Markets has announced the addition of the "Refrigerated Display Cases Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 - 2019" report to its offerings.
Partners Real Estate Investment Trust (TSX: PAR.UN) Announces Distribution of $0.04167 Per Unit
Marketwire - Fri Feb 14, 7:22PM CST
Partners Real Estate Investment Trust ("Partners REIT") (TSX: PAR.UN) is pleased to announce a $0.04167 per unit distribution for February 2014. The distribution will be paid on March 17, 2014 to unitholders of record on February 28, 2014.
Partners Real Estate Investment Trust Completes Management Internalization
Marketwire - Fri Feb 14, 3:06PM CST
Partners Real Estate Investment Trust (TSX: PAR.UN) (the "REIT") is pleased to announce that it has terminated its management agreement with McCowan & Associates Ltd. ("McCowan") and completed the internalization of its management, effective February 15, 2014.
Partners Real Estate Investment Trust Announces Senior Management Changes and Update on Ontario Property Acquisition
Marketwire - Tue Feb 11, 1:17PM CST
Partners Real Estate Investment Trust (TSX: PAR.UN) (the "REIT") is pleased to announce the appointments of Ron McCowan as interim-Chief Executive Officer and President and Derrick W. West as Chief Financial Officer effective immediately. Both appointments have been made pursuant to the REIT's management agreement which will be terminated on February 15, 2014 in connection with the previously announced proposed internalization of the REIT's management. Mr. McCowan and Mr. West will continue in these capacities on completion of the internalization process and more details regarding the REIT's internalization are expected to be announced on or about February 14, 2014.
Global Heart Valves and Transcatheter Valves Market Forecast & Opportunities, 2016
M2 - Fri Jan 17, 9:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/s5lnth/global_heart) has announced the addition of the "Global Heart Valves and Transcatheter Valves Market Forecast & Opportunities, 2016" report to their offering. According to the report,it is estimated that by 2020, 15-25 percent of the population in developed countries would be > 65 year. Heart valve diseases are more common in the elderly especially in the ages > 60-65. A greater number of elderly populations are expected to adopt heart valve repair or replacement therapies owing to access to a healthcare infrastructure. Further, developing countries are also revamping their healthcare infrastructures and enabling accessibility. This in turn is expected to boost market growth in developing countries. Partnerships such as collaboration toward development of new products or manufacturing medical devices are growing among vendors. For example, Boston Scientific partnered with Sorin Group in July 2013 for manufacturing of its product Lotus Transcatheter heart valve system. Through this partnership, Boston Scientific is expected to compete with the top vendors such as Edward Lifesciences and Medtronic in the Transcatheter Heart Valve market in Europe. Further, the report states that the high cost associated with open heart surgeries and minimally non-invasive methods of valve replacement methods like TAVR are likely to restrict the market to affluent patients. The scenario is likely to impact during most of the forecast period. However, by 2020, the market is expected to witness an increase in availability of THV equipment and competition among vendors could decrease the cost of these devices and improve the adoption rate in the future. The key vendors dominating this market space are: - Edward Life Science Corp. - Medtronic Inc. - Sorin Group - St Jude Medical Inc Key Topics Covered: 01. Executive Summary 02. Scope of the Report 03. Market Research Methodology 04. List of Abbreviations 05. Introduction 06. Market Landscape 07. Market Segmentation by Category 08. Global Heart Valve Market 09. Market Segmentation of Heart Valve Market 10. Global Transcatheter Heart Valve Market 11. Geographical Segmentation 12. Key Leading Countries 13. Buying Criteria 14. Market Growth Drivers 15. Drivers and their Impact 16. Market Challenges 17. Impact of Drivers and Challenges 18. Market Trends 19. Trends and their Impact 20. Vendor Landscape 21. Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/s5...obal_heart
Chinese Varicella Vaccine Market Report 2013
M2 - Fri Jan 17, 9:31AM CST
Research and Markets (http://www.researchandmarkets.com/research/3bc6nc/2013_deep) has announced the addition of the "Chinese Varicella Vaccine Market Report 2013" report to their offering. "Chinese Varicella Vaccine Market Report 2013", is a concise and in-depth research report on the Chinese Varicella Vaccine industry. The report begins by giving a definition of varicella vaccine including information on classification, industry chain and other related information. The data analyses manufacturing technology and product specifications and gives summary statistics on major manufacturers including details on capacity, production, supply, demand, shortage, selling price, cost, gross margin, production value and Chinese market share. The report also discusses the 4 Million Bottles/year Varicella Vaccine project feasibility analysis and investment return analysis, and gives related research conclusions and a development trend analysis of the industry. Key Topics Covered: 1 Varicella Vaccine Industry Overview 2 Varicella Vaccine Industry Chain Analysis 3 Varicella Vaccine Production Supply Sales Demand Market Status and Forecast 4 Varicella Vaccine Key Manufacturers Research 5 Varicella Vaccine New Project Investment Feasibility Analysis 6 Varicella Vaccine Industry Research Conclusions Companies Mentioned - Changchun BCHT Biotechnology - Changchun Changsheng Life Sciences Ltd - Changchun Keygen Biological Products Co.,Ltd - GlaxoSmithKline - Shanghai Institute of Biological Products Co.,Ltd For more information visit http://www.researchandmarkets.com/research/3bc6nc/2013_deep About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Partners Real Estate Investment Trust Announces Closing of Assignment of Management Agreement
Marketwire - Sun Dec 29, 7:01PM CST
Partners REIT (TSX: PAR.UN) (the "REIT" or "Partners REIT") is pleased to announce the closing of the proposed acquisition by McCowan and Associates Ltd. ("McCowan") of the rights and duties of League Asset Corp. and certain related entities ("League") under the REIT's existing management agreement (the "Transaction"). The Transaction was previously announced on December 15, 2013.
Partners Real Estate Investment Trust to Acquire Four New Ontario Properties
Marketwire - Wed Dec 18, 9:01PM CST
Partners Real Estate Investment Trust (TSX: PAR.UN) (the "REIT" or "Partners REIT") announced today that it has entered into an purchase and sale agreement (the "Agreement") to acquire four retail centers in Ontario (collectively, the "Properties"). The Properties are located in Hamilton, London, Kemptville and North Bay and total approximately 695,500 square feet of gross leasable area. The tenant roster of the Properties includes Shoppers Drug Mart, Winners, Giant Tiger and Dollar Tree. The Properties are estimated to generate annualized Net Operating Income in the aggregate of approximately $7,250,000.
Partners Real Estate Investment Trust Announces Proposal to Stabilize the REIT's Management and to Accelerate Internalization Plans
Marketwire - Sun Dec 15, 7:01PM CST
Partners REIT (TSX: PAR.UN) (the "REIT" or "Partners REIT") announced today that the Board of Trustees has entered into an arrangement intended to accelerate the REIT's internalization to no later than February 15, 2014.
(0)
(0)Partners Real Estate (PTSRF) Stock Research Links
Scroll down for more posts ▼